BioMarin Pharmaceutical Inc. (BMRN)

Oncology Corporate Profile

Stock Performance

87.7200
-0.9900

HQ Location

770 Lindaro Street
San Rafael, CA 94910

Company Description

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises five approved products and multiple clinical and pre-clinical product candidates.

Website: http://www.bmrn.com

This company does not have any commercial products

This company does not have any pipeline products

Pipeline image

Source


http://www.bmrn.com

Recent News Headlines

Blog Coverage Cempra Announced Positive Results from the Phase-III Study for the Treatment of Acute Bacterial Skin and Skin Structure Infections

2/27/2017 01:01 pm

[Accesswire] - Upcoming AWS Coverage on BioMarin Pharmaceutical Post-Earnings Results LONDON, UK / ACCESSWIRE / February 27, 2017 / Active Wall St. blog coverage looks at the headline from Chapel Hill, North Carolina-based ...

BioMarin reports 4Q loss

2/23/2017 09:03 pm

BioMarin reports 4Q loss

2/23/2017 09:03 pm

BioMarin Announces Fourth Quarter and Full Year 2016 Financial Results

2/23/2017 09:00 pm

[PR Newswire] - SAN RAFAEL, Calif., Feb. 23, 2017 /PRNewswire/ -- Financial Highlights (in millions of U.S. dollars, except per share data, unaudited) Three Months Ended December 31, Twelve Months Ended December 31, 2016 ...

Blog Coverage Celgene's Multiple Sclerosis Drug Reported Positive Phase-III Results

2/21/2017 01:01 pm

[Accesswire] - Upcoming AWS Coverage on BioMarin Pharmaceutical Post-Earnings Results LONDON, UK / ACCESSWIRE / February 21, 2017 / Active Wall St. blog coverage looks at the headline from Celgene Corp. (NASDAQ: CELG ...